Broken String Biosciences Closes $15M Series A Funding Round
– Funds to support further development and commercialization of the Company’s INDUCE-seq DNA break mapping technology – Platform technology provides in situ off-target measurement in clinically relevant cells to accelerate the progression of cell and gene therapy programs – New investors include Illumina Ventures, Mérieux Equity Partners, and HERAN Partners September 18, 2023 04:17 AM Eastern Daylight Time CAMBRIDGE, England–(BUSINESS WIRE)–Broken String Biosciences (“Broken String”), a genomics … Continue reading Broken String Biosciences Closes $15M Series A Funding Round